Project Number 1R44AG060846-01 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for First-in-human study of MW151, a novel drug targeting neuroinflammation Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator SHIFRIN, VICTOR Principal Investigator First Name VICTOR Principal Investigator Last Name SHIFRIN Awardee Organization IMMUNOCHEM THERAPEUTICS, LLC Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-17-064: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44) FY Overall Cost $499,320 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
